Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is
responsible for the outbreak of coronavirus disease 19 (COVID-19) and was first identified in …

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic spreads, it
is becoming increasingly evident that coronavirus disease 2019 (COVID-19) is not limited to …

Abstract Introduction Coronavirus disease 2019 (COVID-19) causes a hypercoagulable
state. Several autopsy studies have found microthrombi in pulmonary circulation. Methods In …

COVID-19 has been occasionally linked to histologically confirmed cutaneous vasculitis and
a Kawasaki-like vasculitis, with these entities generally having minimal or no lung …

Abstract Purpose of Review The present review discusses the peripheral nervous system
(PNS) manifestations associated with coronavirus disease 2019 (COVID-19). Recent …

Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

COVID-19 is a systemic infection that exerts significant impact on the metabolism. Yet, there
is little information on how SARS-CoV-2 affects metabolism. Using NMR spectroscopy, we …

Endothelial cells have emerged as key players in SARS-CoV-2 infection and COVID-19
inflammatory pathologies. Dysfunctional endothelial cells can promote chronic inflammation …

Introduction COVID-19 infections are associated with a high prevalence of venous
thromboembolism, particularly pulmonary embolism (PE). It is suggested that COVID-19 …